1. Home
  2. EVOK vs OCTO Comparison

EVOK vs OCTO Comparison

Compare EVOK & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • OCTO
  • Stock Information
  • Founded
  • EVOK 2007
  • OCTO 1966
  • Country
  • EVOK United States
  • OCTO United States
  • Employees
  • EVOK N/A
  • OCTO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • OCTO
  • Sector
  • EVOK Health Care
  • OCTO
  • Exchange
  • EVOK Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • EVOK 5.4M
  • OCTO 4.2M
  • IPO Year
  • EVOK 2013
  • OCTO N/A
  • Fundamental
  • Price
  • EVOK $5.53
  • OCTO $1.51
  • Analyst Decision
  • EVOK
  • OCTO
  • Analyst Count
  • EVOK 0
  • OCTO 0
  • Target Price
  • EVOK N/A
  • OCTO N/A
  • AVG Volume (30 Days)
  • EVOK 476.4K
  • OCTO 3.0M
  • Earning Date
  • EVOK 08-14-2025
  • OCTO 08-19-2025
  • Dividend Yield
  • EVOK N/A
  • OCTO N/A
  • EPS Growth
  • EVOK N/A
  • OCTO N/A
  • EPS
  • EVOK N/A
  • OCTO N/A
  • Revenue
  • EVOK $12,794,859.00
  • OCTO $43,871,615.00
  • Revenue This Year
  • EVOK $57.82
  • OCTO N/A
  • Revenue Next Year
  • EVOK $59.12
  • OCTO N/A
  • P/E Ratio
  • EVOK N/A
  • OCTO N/A
  • Revenue Growth
  • EVOK 70.02
  • OCTO N/A
  • 52 Week Low
  • EVOK $1.94
  • OCTO $0.98
  • 52 Week High
  • EVOK $12.32
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 54.74
  • OCTO 51.06
  • Support Level
  • EVOK $4.61
  • OCTO $1.33
  • Resistance Level
  • EVOK $7.04
  • OCTO $1.63
  • Average True Range (ATR)
  • EVOK 0.49
  • OCTO 0.10
  • MACD
  • EVOK 0.03
  • OCTO -0.02
  • Stochastic Oscillator
  • EVOK 37.86
  • OCTO 58.14

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.

Share on Social Networks: